|Day Low/High||39.53 / 39.98|
|52 Wk Low/High||31.43 / 48.25|
Here's what Jim Cramer expects to hear from GSK at this week's investor meeting.
CVAC is now working on a 'next generation' COVID-19 vaccine candidate with GlaxoSmithKline.
They have been wonderful plays for those that have used covered calls on the dips in the stocks as they always seem to rebound.
Aurinia Pharma has some positive catalysts, and I am taking partial gains in cannabis names as they remain strong.
Plus, stay nimble as the road just ahead could become a bit more treacherous than many may think.
A look at the charts of Advanced Micro Devices and Tesla, plus a review of the 'broadening' market action from Thursday.
Even more important than fiscal support moving forward would be the concept of Covid-19 very soon being effectively treatable for the public.
Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.
Pfizer is a quality dividend stock that's now trading at a discount.
Often hidden reasons are lurking below when there's maximum confusion, and here's what they are.
6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.
European markets have been slumping for years, but the time for those countries to shine again may finally be around the corner.
Our fate is in the hands of a few dozen companies with a dizzying array of clinical trials, and whoever gets there first is gonna make a fortune.
Let's check out the charts of this healthcare stock.
Do you know what a company does, does it do it well, and is there anything going on that could change the trajectory?
I like putting some of my money with incredibly successful folks who are well-connected and have a history of success.
WDAY looks ready to break out as traders weigh wether markets are now overbought after this 2-day run.
So what's the narrative? Simple: the recession is ending, it turned out to be a V recession and recovery after all.
Trump administration taps former GlaxoSmithKline exec as head of vaccine task force, and how I'm playing Walmart and Datadog.
Let's look at the stocks that will get crushed and that you can't touch right now.
It's imperative that people get back to work, so we have this great compromise -- let's see how it might play out.
The drugmaker that is partnering with Sanofi to develop a vaccine has seen its shares push higher after declining to a low in late March.
There is no joy in stockville -- instead we have big companies with stocks rising. Here's why that is and what you need to understand about the rally amid the crisis.
We've seen some high quarterly dividend increases of late, so let's pick out the crème of the crop.
Our latest analysis and trading strategy for the the big pharma stock.
Analysts from the independent research firm review their picks from last year and share their new favorites.
Shares of the pharma company have broken out on our Point and Figure chart.
These stocks are priced for total imperfection. That's just what you want.
The long-term technical view of GSK is very bullish.